{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:17Z","timestamp":1787032817351,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,3]]},"DOI":"10.7759\/cureus.13665","type":"journal-article","created":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T06:38:15Z","timestamp":1614753495000},"source":"Crossref","is-referenced-by-count":29,"title":["Euglycemic Diabetic Ketoacidosis and Sodium-Glucose Cotransporter-2 Inhibitors: A Focused Review of Pathophysiology, Risk Factors, and Triggers"],"prefix":"10.7759","author":[{"given":"Manoj R","family":"Somagutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuchalambal","family":"Agadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Hange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly S","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkan","family":"Batti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard O","family":"Emuze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth O","family":"Amos-Arowoshegbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorin","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Hanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varadha Retna","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kezia","family":"Pormento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h5660","article-title":"Diabetic ketoacidosis in adults","volume":"351","author":"Misra S","year":"2015","unstructured":"Misra S, Oliver NS. Diabetic ketoacidosis in adults. BMJ. 2015, 351:5660. 10.1136\/bmj.h5660","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2015.12.007","article-title":"The evolution of diabetic ketoacidosis: an update of its etiology, pathogenesis, and management","volume":"65","author":"Nyenwe EA","year":"2016","unstructured":"Nyenwe EA, Kitabchi AE. The evolution of diabetic ketoacidosis: an update of its etiology, pathogenesis, and management. Metabolism. 2016, 65:507-21. 10.1016\/j.metabol.2015.12.007","journal-title":"Metabolism"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5866.578","article-title":"Euglycaemic diabetic ketoacidosis","volume":"9","author":"Munro JF","year":"1973","unstructured":"Munro JF, Campbell IW, McCuish AC, Duncan LJ. Euglycaemic diabetic ketoacidosis. Br Med J. 1973, 9:578-80. 10.1136\/bmj.2.5866.578","journal-title":"Br Med J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000311","article-title":"An update on SGLT2 inhibitors for the treatment of diabetes mellitus","volume":"24","author":"Hsia DS","year":"2017","unstructured":"Hsia DS, Grove O, Cefalu WT. An update on SGLT2 inhibitors for the treatment of diabetes mellitus. Curr Opin Endocrinol Diabetes Obes. 2017, 24:73-9. 10.1097\/MED.0000000000000311","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2174\/1573399812666160421121307","article-title":"Euglycemic diabetic ketoacidosis: a review","volume":"13","author":"Modi A","year":"2017","unstructured":"Modi A, Agrawal A, Morgan F. Euglycemic diabetic ketoacidosis: a review. Curr Diabetes Rev. 2017, 13:315-21. 10.2174\/1573399812666160421121307","journal-title":"Curr Diabetes Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-17-0081","article-title":"Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma","volume":"2017","author":"Rawla P","year":"2017","unstructured":"Rawla P, Vellipuram AR, Bandaru SS, Raj JP. Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma. Endocrinol Diabetes Metab Case Rep. 2017, 2017:17-0081. 10.1530\/EDM-17-0081","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1881","article-title":"SGLT 2 inhibitors: a systematic review of diabetic ketoacidosis and related risk factors in the primary literature","volume":"37","author":"Burke KR","year":"2017","unstructured":"Burke KR, Schumacher CA, Harpe SE. SGLT 2 inhibitors: a systematic review of diabetic ketoacidosis and related risk factors in the primary literature. Pharmacotherapy. 2017, 37:187-94. 10.1002\/phar.1881","journal-title":"Pharmacotherapy"},{"key":"ref8","article-title":"Euglycemic diabetic ketoacidosis due to gastroparesis, a local experience","volume":"112","author":"Legaspi R","year":"2015","unstructured":"Legaspi R, Narciso P. Euglycemic diabetic ketoacidosis due to gastroparesis, a local experience. J Ark Med Soc. 2015, 112:62-3.","journal-title":"J Ark Med Soc"},{"key":"ref9","article-title":"Diabetic ketoacidosis occurring with lower blood glucose levels in pregnancy: a report of two cases","volume":"57","author":"Madaan M","year":"2012","unstructured":"Madaan M, Aggarwal K, Sharma R, Trivedi SS. Diabetic ketoacidosis occurring with lower blood glucose levels in pregnancy: a report of two cases. J Reprod Med. 2012, 57:452-5.","journal-title":"J Reprod Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2018.02.004","article-title":"Sodium-glucose cotransporter-2 inhibitors induced eu-glycemic diabetic ketoacidosis: the first report in a type 2 diabetic (T2D) Taiwanese and literature review of possible pathophysiology and contributing factors","volume":"117","author":"Lin YH","year":"2018","unstructured":"Lin YH. Sodium-glucose cotransporter-2 inhibitors induced eu-glycemic diabetic ketoacidosis: the first report in a type 2 diabetic (T2D) Taiwanese and literature review of possible pathophysiology and contributing factors. J Formos Med Assoc. 2018, 117:849-54. 10.1016\/j.jfma.2018.02.004","journal-title":"J Formos Med Assoc"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000152","article-title":"Sodium-glucose cotransport","volume":"24","author":"Poulsen SB","year":"2015","unstructured":"Poulsen SB, Fenton RA, Rieg T, et al.. Sodium-glucose cotransport. Curr Opin Nephrol Hypertens. 2015, 24:463-9. 10.1097\/MNH.0000000000000152","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12987","article-title":"Cardiorenal protective effect of sodium-glucose cotransporter 2 inhibitors and mitochondrial function","volume":"10","author":"Lee HK","year":"2019","unstructured":"Lee HK. Cardiorenal protective effect of sodium-glucose cotransporter 2 inhibitors and mitochondrial function. J Diabetes Investig. 2019, 10:557-9. 10.1111\/jdi.12987","journal-title":"J Diabetes Investig"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-0330","article-title":"CV protection in the EMPA-REG OUTCOME trial: a \u201cthrifty substrate\u201d hypothesis","volume":"39","author":"Ferrannini E","year":"2016","unstructured":"Ferrannini E, Mark M, and Mayoux E. CV protection in the EMPA-REG OUTCOME trial: a \u201cthrifty substrate\u201d hypothesis. Diabetes Care. 2016, 39:1108-14. 10.2337\/dc16-0330","journal-title":"Diabetes Care"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-S010","article-title":"Cardiovascular disease and risk management: standards of medical care in diabetes-2020","volume":"43","author":"American Diabetes Association","year":"2020","unstructured":"American Diabetes Association. Cardiovascular disease and risk management: standards of medical care in diabetes-2020. Diabetes Care. 2020, 43:111-34. 10.2337\/dc20-S010","journal-title":"Diabetes Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55080462","article-title":"Nephrology consultation for severe SGLT2 inhibitor-induced ketoacidosis in type 2 diabetes: case report","volume":"55","author":"Nappi F","year":"2019","unstructured":"Nappi F, La Verde A, Carfora G, et al.. Nephrology consultation for severe SGLT2 inhibitor-induced ketoacidosis in type 2 diabetes: case report. Medicina. 2019, 55:462. 10.3390\/medicina55080462","journal-title":"Medicina"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omw061","article-title":"The DKA that wasn't: a case of euglycemic diabetic ketoacidosis due to empagliflozin","volume":"2016","author":"Candelario N","year":"2016","unstructured":"Candelario N, Wykretowicz J. The DKA that wasn't: a case of euglycemic diabetic ketoacidosis due to empagliflozin. Oxf Med Case Reports. 2016, 2016:144-6. 10.1093\/omcr\/omw061","journal-title":"Oxf Med Case Reports"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99123","article-title":"Canagliflozin triggers the FGF23\/1,25-dihydroxyvitamin D\/PTH axis in healthy volunteers in a randomized crossover study","volume":"3","author":"Blau JE","year":"2018","unstructured":"Blau JE, Bauman V, Conway EM, et al.. Canagliflozin triggers the FGF23\/1,25-dihydroxyvitamin D\/PTH axis in healthy volunteers in a randomized crossover study. JCI Insight. 2018, 3:99123. 10.1172\/jci.insight.99123","journal-title":"JCI Insight"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1039%2Fc8md00183a","article-title":"Sodium-glucose cotransporter 2 (SGLT-2) inhibitors: a new antidiabetic drug class","volume":"9","author":"da Silva PN","year":"2018","unstructured":"da Silva PN, da Concei\u00e7\u00e3o RA, do Couto Maia R, de Castro Barbosa ML. Sodium-glucose cotransporter 2 (SGLT-2) inhibitors: a new antidiabetic drug class. MedChemComm. 2018, 9:1273-81. 10.1039%2Fc8md00183a","journal-title":"MedChemComm"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1264-y","article-title":"Euglycemic ketosis in patients with type 2 diabetes on SGLT2-inhibitor therapy\u2014an emerging problem and solutions offered by diabetes technology","volume":"56","author":"Pf\u00fctzner A","year":"2017","unstructured":"Pf\u00fctzner A, Klonoff D, Heinemann L, Ejskjaer N, Pickup J. Euglycemic ketosis in patients with type 2 diabetes on SGLT2-inhibitor therapy\u2014an emerging problem and solutions offered by diabetes technology. Endocrine. 2017, 56:212-6. 10.1007\/s12020-017-1264-y","journal-title":"Endocrine"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.2147","article-title":"Euglycemic diabetic ketoacidosis in association with dapagliflozin use after gastric sleeve surgery in a patient with type II diabetes mellitus","volume":"7","author":"Banakh I","year":"2019","unstructured":"Banakh I, Kung R, Gupta S, Matthiesson K, Tiruvoipati R. Euglycemic diabetic ketoacidosis in association with dapagliflozin use after gastric sleeve surgery in a patient with type II diabetes mellitus. Clin Case Rep. 2019, 7:1087-90. 10.1002\/ccr3.2147","journal-title":"Clin Case Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/jpen.1594","article-title":"Ketoacidosis in euglycemic patients with type 2 diabetes after abdominal surgery","volume":"43","author":"Segebrecht R","year":"2019","unstructured":"Segebrecht R, Moncure M, Bennett A, Geehan D, W Van Way C 3rd, Weide L. Ketoacidosis in euglycemic patients with type 2 diabetes after abdominal surgery. JPEN J Parenter Enteral Nutr. 2019, 43:937-40. 10.1002\/jpen.1594","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2337\/cd16-0001","article-title":"Sodium-glucose cotransporter 2 inhibitors and euglycemic diabetic ketoacidosis: metabolic acidosis with a twist","volume":"34","author":"Jaberi A","year":"2016","unstructured":"Jaberi A, Seth B, Steenkamp D, Alexanian S, Borkan SC. Sodium-glucose cotransporter 2 inhibitors and euglycemic diabetic ketoacidosis: metabolic acidosis with a twist. Clin Diabetes. 2016, 34:214-6. 10.2337\/cd16-0001","journal-title":"Clin Diabetes"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1177\/1941874419835035","article-title":"Postoperative euglycemic diabetic ketoacidosis and encephalopathy related to SGLT-2 inhibitors: a case report and discussion of diabetes treatment and \u201csweet pee encephalopathy\u201d in perioperative hospital management","volume":"10","author":"Mackintosh C","year":"2020","unstructured":"Mackintosh C, Tewari A, Siegel J, Wang RD, Freeman W. Postoperative euglycemic diabetic ketoacidosis and encephalopathy related to SGLT-2 inhibitors: a case report and discussion of diabetes treatment and \u201csweet pee encephalopathy\u201d in perioperative hospital management. Neurohospitalist. 2020, 10:51-4. 10.1177\/1941874419835035","journal-title":"Neurohospitalist"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-018-3548-6","article-title":"Normal blood glucose and high blood ketones in a critically unwell patient with T1DM post-bariatric surgery: a case of euglycemic diabetic ketoacidosis","volume":"29","author":"Dowsett J","year":"2019","unstructured":"Dowsett J, Humphreys R, Krones R. Normal blood glucose and high blood ketones in a critically unwell patient with T1DM post-bariatric surgery: a case of euglycemic diabetic ketoacidosis. Obes Surg. 2019, 29:347-9. 10.1007\/s11695-018-3548-6","journal-title":"Obes Surg"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4496","article-title":"Post-surgical euglycemic diabetic ketoacidosis in a patient on empagliflozin in the intensive care unit","volume":"11","author":"Bteich F","year":"2019","unstructured":"Bteich F, Daher G, Kapoor A, Charbek E, Kamel G. Post-surgical euglycemic diabetic ketoacidosis in a patient on empagliflozin in the intensive care unit. Cureus. 2019, 11:4496. 10.7759\/cureus.4496","journal-title":"Cureus"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1089\/pancan.2018.0016","article-title":"Euglycemic diabetic ketoacidosis due to sodium-glucose cotransporter 2 inhibitor use in two patients undergoing pancreatectomy","volume":"4","author":"Pace DJ","year":"2018","unstructured":"Pace DJ, Dukleska K, Phillips S, Gleason V, Yeo CJ. Euglycemic diabetic ketoacidosis due to sodium-glucose cotransporter 2 inhibitor use in two patients undergoing pancreatectomy. J Pancreat Cancer. 2018, 4:95-9. 10.1089\/pancan.2018.0016","journal-title":"J Pancreat Cancer"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-19-0087","article-title":"Prolonged acidosis is a feature of SGLT2i-induced euglycaemic diabetic ketoacidosis","volume":"2019","author":"Rafey MF","year":"2019","unstructured":"Rafey MF, Butt A, Coffey B, Reddington L, Devitt A, Lappin D, Finucane FM. Prolonged acidosis is a feature of SGLT2i-induced euglycaemic diabetic ketoacidosis. Endocrinol Diabetes Metab Case Rep. 2019, 2019:19-0087. 10.1530\/EDM-19-0087","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4158\/ACCR-2020-0314","article-title":"Successful reimplantation of a very low carbohydrate ketogenic diet after SGLT-2 inhibitor-associated euglycemic diabetic ketoacidosis","volume":"6","author":"Fieger EI","year":"2020","unstructured":"Fieger EI, Fadel KM, Modarres AH, Wickham EP 3rd, Wolver SE. Successful reimplantation of a very low carbohydrate ketogenic diet after SGLT-2 inhibitor-associated euglycemic diabetic ketoacidosis. AACE Clin Case Rep. 2020, 6:330-3. 10.4158\/ACCR-2020-0314","journal-title":"AACE Clin Case Rep"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-SUN-177","article-title":"SUN-177 house of carbs: the path to euglycemic DKA in patients with diabetes on SGLT2 inhibitors","volume":"3","author":"Islam J","year":"2019","unstructured":"Islam J, Rodriguez-Martinez R, Mba MU, Ahmad A. SUN-177 house of carbs: the path to euglycemic DKA in patients with diabetes on SGLT2 inhibitors. J Endocr Soc. 2019, 3:177. 10.1210\/js.2019-SUN-177","journal-title":"J Endocr Soc"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.5811\/cpcem.2020.2.45904","article-title":"Euglycemic diabetic ketoacidosis in concurrent very low-carbohydrate diet and sodium-glucose transporter-2 inhibitor use: a case report","volume":"4","author":"Earle M","year":"2020","unstructured":"Earle M, Ault B, Bonney C. Euglycemic diabetic ketoacidosis in concurrent very low-carbohydrate diet and sodium-glucose transporter-2 inhibitor use: a case report. Clin Pract Cases Emerg Med. 2020, 4:185-8. 10.5811\/cpcem.2020.2.45904","journal-title":"Clin Pract Cases Emerg Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10199","article-title":"Euglycemic diabetic ketoacidosis precipitated by a keto diet: importance of dietary history in diagnosis","volume":"12","author":"Shaikh S","year":"2020","unstructured":"Shaikh S, Mohamed MM, Mujeeb A, Shaikh F, Harris B. Euglycemic diabetic ketoacidosis precipitated by a keto diet: importance of dietary history in diagnosis. Cureus. 2020, 12:10199. 10.7759\/cureus.10199","journal-title":"Cureus"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3901741","article-title":"Euglycemic diabetic ketoacidosis secondary to dapagliflozin in a patient with colon malignancy","volume":"2019","author":"Papadokostaki E","year":"2019","unstructured":"Papadokostaki E, Liberopoulos E. Euglycemic diabetic ketoacidosis secondary to dapagliflozin in a patient with colon malignancy. Case Rep Endocrinol. 2019, 2019:3901741. 10.1155\/2019\/3901741","journal-title":"Case Rep Endocrinol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016076","article-title":"Ketosis-prone diabetes mellitus in an obese adolescent: a case report","volume":"98","author":"Tan H","year":"2019","unstructured":"Tan H, Wang C, Yu Y. Ketosis-prone diabetes mellitus in an obese adolescent: a case report. Medicine. 2019, 98:16076. 10.1097\/MD.0000000000016076","journal-title":"Medicine"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-01930-6","article-title":"Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review","volume":"21","author":"Sampani E","year":"2020","unstructured":"Sampani E, Sarafidis P, Dimitriadis C, et al.. Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review. BMC Nephrol. 2020, 21:276. 10.1186\/s12882-020-01930-6","journal-title":"BMC Nephrol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2019.12.006","article-title":"SGLT2 inhibitor-induced euglycemic diabetic ketoacidosis: a case report","volume":"2","author":"Wang KM","year":"2020","unstructured":"Wang KM, Isom RT. SGLT2 inhibitor-induced euglycemic diabetic ketoacidosis: a case report. Kidney Med. 2020, 2:218-21. 10.1016\/j.xkme.2019.12.006","journal-title":"Kidney Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.2337\/cd19-0035","article-title":"Sodium-glucose cotransporter 2 inhibitor-associated prolonged euglycemic diabetic ketoacidosis in type 2 diabetes: a case report and literature review","volume":"38","author":"Yehya A","year":"2020","unstructured":"Yehya A, Sadhu A. Sodium-glucose cotransporter 2 inhibitor-associated prolonged euglycemic diabetic ketoacidosis in type 2 diabetes: a case report and literature review. Clin Diabetes. 2020, 38:112-6. 10.2337\/cd19-0035","journal-title":"Clin Diabetes"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6450563","article-title":"Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient presenting with acute pancreatitis","volume":"2018","author":"Badwal K","year":"2018","unstructured":"Badwal K, Tariq T, Peirce D. Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient presenting with acute pancreatitis. Case Rep Endocrinol\r\n. 2018, 2018:6450563. 10.1155\/2018\/6450563","journal-title":"Case Rep Endocrinol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2020_533","article-title":"Latent autoimmune diabetes in adults: a review of clinically relevant issues","volume":"1307","author":"Hern\u00e1ndez M","year":"2021","unstructured":"Hern\u00e1ndez M, Mauricio D. Latent autoimmune diabetes in adults: a review of clinically relevant issues. Adv Exp Med Biol. 2021, 1307:29-41. 10.1007\/5584_2020_533","journal-title":"Adv Exp Med Biol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4384","article-title":"Euglycemic diabetic ketoacidosis in the setting of SGLT2 inhibitor use and hypertriglyceridemia: a case report and review of literature","volume":"11","author":"Gajjar K","year":"2019","unstructured":"Gajjar K, Luthra P. Euglycemic diabetic ketoacidosis in the setting of SGLT2 inhibitor use and hypertriglyceridemia: a case report and review of literature. Cureus. 2019, 11:4384. 10.7759\/cureus.4384","journal-title":"Cureus"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.4158\/EP161292.PS","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis","volume":"22","author":"Handelsman Y","year":"2016","unstructured":"Handelsman Y, Henry RR, Bloomgarden ZT, et al.. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis. Endocr Pract. 2016, 22:753-62. 10.4158\/EP161292.PS","journal-title":"Endocr Pract"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7331","article-title":"Euglycemic diabetic ketoacidosis in a young pregnant woman precipitated by urinary tract infection","volume":"12","author":"Muppidi V","year":"2020","unstructured":"Muppidi V, Meegada S, Challa T, Siddamreddy S, Samal S. Euglycemic diabetic ketoacidosis in a young pregnant woman precipitated by urinary tract infection. Cureus. 2020, 12:7331. 10.7759\/cureus.7331","journal-title":"Cureus"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1747850","article-title":"Euglycemic diabetic ketoacidosis in the ICU: 3 case reports and review of literature","volume":"2018","author":"Lucero P","year":"2018","unstructured":"Lucero P, Chapela S. Euglycemic diabetic ketoacidosis in the ICU: 3 case reports and review of literature. Case Rep Crit Care. 2018, 2018:1747850. 10.1155\/2018\/1747850","journal-title":"Case Rep Crit Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/51976-euglycemic-diabetic-ketoacidosis-and-sodium-glucose-cotransporter-2-inhibitors-a-focused-review-of-pathophysiology-risk-factors-and-triggers","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:30:12Z","timestamp":1707489012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/51976-euglycemic-diabetic-ketoacidosis-and-sodium-glucose-cotransporter-2-inhibitors-a-focused-review-of-pathophysiology-risk-factors-and-triggers"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,3]]},"references-count":42,"URL":"https:\/\/doi.org\/10.7759\/cureus.13665","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,3]]}}}